08 SUZUKI FORENZA Ignition W Ranking TOP20 Key $30 08 SUZUKI FORENZA Ignition W/Key eBay Motors Parts & Accessories Boat Parts $30,/exumbral160618.html,08,Ignition,eBay Motors , Parts & Accessories , Boat Parts,vietbox.vn,FORENZA,SUZUKI,W/Key 08 SUZUKI FORENZA Ignition W Ranking TOP20 Key $30,/exumbral160618.html,08,Ignition,eBay Motors , Parts & Accessories , Boat Parts,vietbox.vn,FORENZA,SUZUKI,W/Key $30 08 SUZUKI FORENZA Ignition W/Key eBay Motors Parts & Accessories Boat Parts

08 SUZUKI FORENZA Ignition W Direct store Ranking TOP20 Key

08 SUZUKI FORENZA Ignition W/Key

$30

08 SUZUKI FORENZA Ignition W/Key

|||

Item specifics

Condition:
Used
Brand:
SUZUKI
Year:
2008
Mileage:
0
Model:
FORENZA
Stock Number:
W21730
Tag Number:
0000198835



08 SUZUKI FORENZA Ignition W/Key

Intro Pullout Text Widget

a leading international journal from BMJ and BSG, publishes cutting-edge gastroenterology and hepatology research and reviews

Impact Factor: 23.059
Citescore: 35.6
All metrics >>

Gut is a Plan S compliant Transformative Journal.

Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles by leading authorities describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future.

Gut is an official journal of the British Society of Gastroenterology and has two companion titles: Frontline Gastroenterology for education and practice and BMJ Open Gastroenterology for sound science clinical research.

Editor-in-Chief: Professor Emad El-Omar, University of New South Wales, Sydney, Australia
Meet the Editor and Editorial Board

TOP CITED ARTICLES
Read the most cited articles from Gut and BMJ Open Gastroenterology

SOCIAL MEDIA AND MULTIMEDIA
Keep up-to-date with Gut on Twitter and Facebook, and access videos on our YouTube channel.

The Gut blog is now live - read the Earl's Engine Oil Cooler 807ERL; Ultra Pro X-Wide.

Gut publishes podcasts discussing highlights from its issues. Subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.

 

Latest Content

COVID-19 Gastroenterology Collection

 

Our new online collection highlights all research relating to the COVID-19 pandemic published by Gut, Frontline Gastroenterology and BMJ Open Gastroenterology. It is updated regularly as new articles are published.

 

The COVID-19 collection includes original research, commentaries, letters and editorials from all three journals published with the British Society of Gastroenterology (BSG)

 

Visit the full BMJ Coronavirus resource collection for all the latest content from across our portfolio

 

Latest Visual Abstract

Visual Abstracts provide summaries of the latest research in a single, visual format

View a high-resolution version of the Visual Abstract and read the full article

Vtg The Junior Superstars Running Silks Mountain Dew Jacket Retr

Altmetrics

Podcasts

Featured Video

Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes

To cite: Mingrone G, van Baar AC, Devière J Investigators of the REVITA-2 Study, et al. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial. Gut 2022;71:254-264.

Read the full article here: link
Objective: Hydrothermal duodenal mucosal resurfacing (DMR) is a safe, outpatient endoscopic procedure. REVITA-2, a double-blind, superiority randomised controlled trial, investigates safety and efficacy of DMR using the single catheter Revita system (Revita DMR (catheter and system)), on glycaemic control and liver fat content in type 2 diabetes (T2D).

Conclusions: DMR is safe and exerts beneficial disease-modifying metabolic effects in T2D with or without non-alcoholic liver disease, particularly in patients with high FPG.

Related Content